Herbicidal 2-oxo-nicotinic acid derivatives

Pyridone derivatives with specific structural substitutions provide effective and selective herbicidal activity, addressing the challenge of weed control in crops by enhancing herbicidal efficacy and crop tolerance.

CN119095827APending Publication Date: 2024-12-06SYNGENTA CROP PROTECITON AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380036383.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-27
Filing Date
2023-04-20
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing herbicides do not effectively address the need for selective weed control in crops while maintaining crop plant tolerance, and there is a requirement for herbicides with improved herbicidal activity.

Method used

Development of pyridone derivatives with specific structural substitutions, such as compounds of formula (I), which are formulated into agrochemical compositions for targeted weed control, offering enhanced herbicidal activity and selectivity.

Benefits of technology

The pyridone derivatives demonstrate a high level of herbicidal activity with improved selectivity, allowing for effective weed control without harming crop plants, and can be applied pre- or post-emergence to ensure crop tolerance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095827A_ABST
    Figure CN119095827A_ABST
Patent Text Reader

Abstract

Compounds having the formula (I) wherein the substituents are as defined in claim 1 are disclosed. The invention further relates to herbicidal compositions comprising compounds of formula (I) and to the use of compounds of formula (I) for controlling weeds, in particular in crops of useful plants. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to herbicidal pyridone derivatives, for example as active ingredients, which have herbicidal activity. The invention also relates to agrochemical compositions comprising at least one of these pyridone derivatives, processes for the preparation of these compounds, and the use of these pyridone derivatives or compositions in agriculture or horticulture for controlling weeds, in particular weeds in crops of useful plants.

[0002] EP 0239391, EP 0127313, EP 0040082, GB 2328614 and GB 2182931 describe pyridone derivatives as herbicides.

[0003] According to the present invention, there is provided a compound having formula (I) or a salt thereof:

[0004]

[0005] in

[0006] R 1 is hydrogen, C1-C6 alkyl, phenyl, phenylC1-C2 alkyl, heteroaryl, or heteroarylC1-C2 alkyl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms independently selected from N, O and S, and wherein the phenyl and heteroaryl moieties are each optionally substituted by 1, 2, 3 or 4 residues which may be the same or different and are represented by R 5 The group represented by is substituted;

[0007] R 2 is hydrogen or C1-C6 alkyl;

[0008] R 3 is hydrogen, halogen, cyano, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, or C2-C6 alkynyl;

[0009] R 4 is optionally replaced by 1, 2, 3 or 4 which may be the same or different. 6 The group represented by substituted phenyl;

[0010] R 5 is halogen, cyano, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 alkoxyC1-C6 alkyl, or nitro; and

[0011] R 6It is cyano, nitro, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 alkoxyC1-C6 alkyl, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfonylamino, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 alkylaminocarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylaminocarbonyl, or N,N-di(C1-C4 alkyl)aminocarbonyl.

[0012] Surprisingly, it has been found that the novel compounds of formula (I) have a very advantageous level of herbicidal activity for practical purposes.

[0013] According to a second aspect of the present invention, there is provided an agrochemical composition comprising a herbicidally effective amount of a compound of formula (I) according to the present invention. Such an agricultural composition may further comprise at least one additional active ingredient and / or an agrochemically acceptable diluent or carrier.

[0014] According to a third aspect of the present invention there is provided a method of controlling weeds at a locus, the method comprising applying to the locus a weed controlling amount of a composition comprising a compound of formula (I).

[0015] According to a fourth aspect of the present invention, there is provided use of a compound of formula (I) as a herbicide.

[0016] When substituents are indicated as being "optionally substituted", this means that they may or may not carry one or more identical or different substituents, for example one, two or three R 5 Substituents. For example, C1-C6 alkyl substituted with 1, 2 or 3 halogens may include, but are not limited to -CH2Cl, -CHCl2, -CCl3, -CH2F, -CHF2, -CF3, -CH2CF3 or -CF2CH3 groups. As another example, C1-C6 alkoxy substituted with 1, 2 or 3 halogens may include, but are not limited to CH2ClO-, CHCl2O-, CCl3O-, CH2FO-, CHF2O-, CF3O-, CF3CH2O- or CH3CF2O- groups.

[0017] As used herein, the term "cyano" refers to a -CN group.

[0018] As used herein, the term "halogen" refers to fluorine (fluorine / fluoro), chlorine (chlorine / chloro), bromine (bromine / bromo), or iodine (iodine / iodo).

[0019] As used herein, the term "hydroxy" or "hydroxyl" refers to an -OH group.

[0020] As used herein, the term "nitro" refers to a -NO2 group.

[0021] As used herein, the term "acetyl" refers to a -C(O)CH3 group.

[0022] As used herein, =0 refers to an oxo group, for example, as found in a carbonyl (-C(=0)-) group.

[0023] As used herein, the term "C1-C6 alkyl" refers to a straight or branched hydrocarbon chain group consisting only of carbon atoms and hydrogen atoms, which contains no unsaturation, has one to six carbon atoms, and is attached to the rest of the molecule by a single bond. "C1-C4 alkyl" and "C1-C3 alkyl" should be interpreted accordingly. Examples of C1-C6 alkyls include, but are not limited to, methyl, ethyl, n-propyl, and isomers thereof, such as isopropyl. "C1-C6 alkylene" groups refer to the corresponding definition of C1-C6 alkyls, except that such groups are attached to the rest of the molecule by two single bonds. The term "C1-C2 alkylene" should be interpreted accordingly. Examples of C1-C6 alkylenes include, but are not limited to -CH2-, -CH2CH2- and -(CH2)3-.

[0024] As used herein, the term "C1-C6 haloalkyl" refers to a C1-C6 alkyl group as generally defined above, which is substituted by one or more of the same or different halogen atoms. The terms "C1-C4 haloalkyl" and "C1-C3 haloalkyl" should be interpreted accordingly. Examples of C1-C6 haloalkyl include, but are not limited to, trifluoromethyl.

[0025] As used herein, the term "C1-C6 alkoxy" refers to a group having the formula -OR a A group in which R a is a C1-C6 alkyl group as generally defined above. The terms "C1-C4 alkoxy" and "C1-C3 alkoxy" should be interpreted accordingly. Examples of C1-C6 alkoxy include, but are not limited to, methoxy, ethoxy, 1-methylethoxy (isopropoxy), and propoxy.

[0026] As used herein, the term "C1-C6 haloalkoxy" refers to a C1-C6 alkoxy group as generally defined above, which is substituted with one or more of the same or different halogen atoms. The terms "C1-C4 haloalkoxy" and "C1-C3 haloalkoxy" should be interpreted accordingly. Examples of C1-C6 haloalkoxy include, but are not limited to, trifluoromethoxy.

[0027] As used herein, the term "C2-C6 alkenyl" refers to a straight or branched hydrocarbon chain group consisting solely of carbon atoms and hydrogen atoms, containing at least one double bond which may have an (E)- or (Z)-configuration, having two to six carbon atoms, attached to the remainder of the molecule by a single bond. The term "C2-C3 alkenyl" should be interpreted accordingly. Examples of C2-C6 alkenyl include, but are not limited to, ethenyl / vinyl, prop-1-enyl, prop-2-enyl (allyl), but-1-enyl.

[0028] As used herein, the term "C2-C6 alkynyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having two to six carbon atoms, and attached to the remainder of the molecule by a single bond. The term "C2-C3 alkynyl" should be interpreted accordingly. Examples of C2-C6 alkynyl include, but are not limited to, ethynyl, prop-1-ynyl, but-1-ynyl.

[0029] As used herein, the term "C1-C6 alkoxy C1-C6 alkyl" refers to a b OR a - a group, wherein R b is a C1-C6 alkyl group as generally defined above, and R a is a C1-C6 alkylene group as generally defined above. The terms "C1-C4 alkoxy C1-C4 alkyl" and "C1-C3 alkoxy C1-C3 alkyl" should be interpreted accordingly.

[0030] As used herein, the term "C3-C6 cycloalkyl" refers to a group that is a monocyclic saturated ring system and contains 3 to 6 carbon atoms. The terms "C3-C5 cycloalkyl" and "C3-C4 cycloalkyl" should be interpreted accordingly. Examples of C3-C6 cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.

[0031] As used herein, the term "C3-C6 cycloalkylaminocarbonyl" refers to a C3-C6 cycloalkyl ring attached to the rest of the molecule via a -NHC(O)- linker. Examples of C3-C6 cycloalkylaminocarbonyl include, but are not limited to, cyclopropylcarbamoyl (i.e., cyclopropylaminocarbonyl).

[0032] As used herein, the term "phenyl C1-C2 alkyl" refers to a phenyl ring attached to the rest of the molecule via a C1-C2 alkylene linker as defined above. Examples of phenyl C1-C2 alkyl include, but are not limited to, benzyl and phenylethyl.

[0033] As used herein, the term "heteroaryl" refers to a 5- or 6-membered aromatic monocyclic group containing 1, 2 or 3 heteroatoms independently selected from nitrogen, oxygen and sulfur. Examples of heteroaryl include, but are not limited to, furanyl, pyrrolyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, pyrazinyl, pyridazinyl, pyrimidinyl or pyridyl.

[0034] As used herein, the term "heteroaryl C1-C2 alkyl" refers to a heteroaryl ring as generally defined above attached to the remainder of the molecule via a C1-C2 alkylene linker as defined above.

[0035] As used herein, the term "C1-C6 alkylcarbonyl" refers to a group having the formula -C(O)R a A group in which R a is a C1-C6 alkyl group as generally defined above. Examples of C1-C6 alkylcarbonyl groups include, but are not limited to, acetyl.

[0036] As used herein, the term "C1-C6 alkoxycarbonyl" refers to a group having the formula -C(O)OR a A group in which R a is a C1-C6 alkyl group as generally defined above.

[0037] As used herein, the term "C1-C6 alkylaminocarbonyl" refers to a group having the formula -C(O)NHR a A group in which R a is a C1-C6 alkyl group as generally defined above. Examples of C1-C6 alkylaminocarbonyl groups include, but are not limited to, ethylcarbamoyl (ie, ethylaminocarbonyl).

[0038] As used herein, the term "N,N-di(C1-C4 alkyl)amino" refers to a a )(R b ) group, wherein R a and R b Each is individually a C1-C4 alkyl group as generally defined above. The term "N,N-di(C1-C3 alkyl)amino" should be interpreted accordingly.

[0039] As used herein, the term "N,N-di(C1-C4 alkyl)aminocarbonyl" refers to a group having the formula -C(O)N(R a )(R b ) group, wherein R a and R bEach is individually a C1-C4 alkyl group as generally defined above. The term "N,N-di(C1-C3 alkyl)aminocarbonyl" should be interpreted accordingly. Examples of N,N-di(C1-C4 alkyl)aminocarbonyl include, but are not limited to, dimethylcarbamoyl (i.e., N,N-di(methyl)aminocarbonyl).

[0040] As used herein, the term "C1-C6 alkylsulfanyl" refers to a alkylsulfanyl group having the formula -SR a A group in which R a is a C1-C6 alkyl group as generally defined above. The terms "C1-C4 alkylsulfanyl" and "C1-C3 alkylsulfanyl" should be interpreted accordingly. Examples of C1-C6 alkylsulfanyl include, but are not limited to, methylsulfanyl.

[0041] As used herein, the term "C1-C6 alkylsulfinyl" refers to a group having the formula -S(O)R a A group in which R a is a C1-C6 alkyl group as generally defined above. The terms "C1-C4 alkylsulfinyl" and "C1-C3 alkylsulfinyl" should be interpreted accordingly. Examples of C1-C6 alkylsulfinyl include, but are not limited to, methylsulfinyl.

[0042] As used herein, the term "C1-C6 alkylsulfonyl" refers to a group having the formula -S(O)2R a A group in which R a is a C1-C6 alkyl group as generally defined above. The terms "C1-C4 alkylsulfonyl" and "C1-C3 alkylsulfonyl" should be interpreted accordingly. Examples of C1-C6 alkylsulfonyl include, but are not limited to, methylsulfonyl.

[0043] As used herein, the term "C1-C6 alkylsulfonylamino" refers to a group having the formula -NHS(O)2R a A group in which R a is a C1-C6 alkyl group as generally defined above.

[0044] The presence of one or more possible stereogenic elements in a compound of formula (I) means that the compound may exist in optical isomeric forms (i.e., enantiomers or diastereomeric forms). As a result of restricted rotation around a single bond, atropisomers may also exist. Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof of compounds of formula (I). Similarly, formula (I) is intended to include all possible tautomers. The present invention includes all possible tautomeric forms of compounds of formula (I).

[0045] In each case, the compounds of formula (I) according to the invention are in free form or in salt form, for example, agronomically useful salt forms. Preferred are salts that the compounds of formula (I) can form with: amines, including primary, secondary and tertiary amines (for example ammonia, dimethylamine and triethylamine); alkali metal bases and alkaline earth metal bases, transition metal bases or quaternary ammonium bases. In a particularly preferred group of embodiments, the compounds of formula (I) can form chlorides or 2,2,2-trifluoroacetates.

[0046] The following list provides information on the substituents R of compounds having formula (I): 1 , R 2 , R 3 , R 4 , R 5 , and R 6 For any of these substituents, any definition given below may be combined with any definition of any other substituent given below or elsewhere in this document.

[0047] R 1 is hydrogen, C1-C6 alkyl, phenyl, phenylC1-C2 alkyl, heteroaryl, or heteroarylC1-C2 alkyl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms independently selected from N, O and S, and wherein the phenyl and heteroaryl moieties are each optionally substituted by 1, 2, 3 or 4 residues which may be the same or different and are represented by R 5 Preferably, R 1 is hydrogen, C1-C6 alkyl, phenyl, phenylC1-C2 alkyl, heteroaryl, or heteroarylC1-C2 alkyl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, and wherein the phenyl and heteroaryl moieties each may be optionally substituted by 1, 2 or 3 residues which may be the same or different and are represented by R 5 More preferably, R 1 is hydrogen, C1-C4 alkyl, phenyl, phenylC1-C2 alkyl, or heteroaryl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N and O, and wherein the phenyl and heteroaryl moieties each may be optionally substituted by 1, 2 or 3 residues which may be the same or different and are represented by R 5 Even more preferably, R 1 is hydrogen, C1-C3 alkyl, phenyl, phenylC1-C2 alkyl, or heteroaryl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing a single nitrogen atom, and wherein the phenyl and heteroaryl moieties each may be optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 More preferably, R1 is hydrogen, methyl, phenyl, phenyl C1-C2 alkyl, or pyridyl, and wherein the phenyl and pyridyl moieties are each optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 Even more preferably, R 1 is hydrogen, methyl, phenyl, phenylmethyl (benzyl), or pyridyl, and wherein the phenyl and pyridyl moieties are each optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented is substituted.

[0048] In one set of embodiments, R 1 is C1-C3 alkyl, phenyl, phenylC1-C2 alkyl, or heteroaryl, wherein each heteroaryl moiety is a 5-membered or 6-membered aromatic monocyclic ring containing a single nitrogen atom, and wherein the phenyl and heteroaryl moieties are each optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 Preferably, R 1 is methyl, phenyl, phenyl C1-C2 alkyl, or pyridyl, and wherein the phenyl and pyridyl moieties are each optionally replaced by 1 or 2 residues which may be the same or different and are represented by R 5 More preferably, R 1 is methyl, phenyl, phenylmethyl (benzyl), or pyridinyl, and wherein the phenyl and pyridinyl moieties are each optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented is substituted.

[0049] In another set of embodiments, R 1 It is methyl, 4-chlorophenyl, 4-fluorophenyl, 3-trifluoromethylphenyl, 2,4-difluorophenyl, 2,4-difluorophenylmethyl, 4-chloro-2-fluorophenyl, 4-chloro-2-fluorophenylmethyl, 4-cyano-2-fluorophenyl, 4-cyano-2-fluorophenylmethyl, 2-fluoro-4-(trifluoromethyl)phenyl, 2-fluoro-4-(trifluoromethyl)phenylmethyl, 2-fluoro-3-(trifluoromethyl)phenyl, 5-chloro-3-fluoro-2-pyridyl, or 3,5-dichloro-2-pyridyl.

[0050] R 2 is hydrogen or C1-C6 alkyl. Preferably, R 2 is hydrogen or C1-C4 alkyl. More preferably, R 2 is hydrogen or C1-C3 alkyl. Even more preferably, R 2 is hydrogen or methyl. Still more preferably, R 2 In one embodiment, R 2 It is a C1-C3 alkyl group, preferably a methyl group.

[0051] R 3is hydrogen, halogen, cyano, hydroxyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, or C2-C6 alkynyl. Preferably, R 3 is hydrogen, halogen, cyano, hydroxyl, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl, C3-C6 cycloalkyl, C2-C4 alkenyl, or C2-C4 alkynyl. More preferably, R 3 is hydrogen, halogen, cyano, hydroxyl, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl, C3-C6 cycloalkyl, C2-C3 alkenyl, or C2-C4 alkynyl. Even more preferably, R 3 is hydrogen, halogen, cyano, hydroxyl, C1-C3 alkyl, C1-C2 alkoxy, C1-C3 alkyl, C3-C4 cycloalkyl, C2-C3 alkenyl, or C2-C3 alkynyl. Still more preferably, R 3 is hydrogen, bromine, chlorine, cyano, hydroxyl, methyl, ethyl, methoxymethyl, cyclopropyl, vinyl, or prop-1-ynyl. In one embodiment, R 3 is hydrogen, bromine, chlorine, hydroxyl, methyl, ethyl, methoxymethyl, cyclopropyl, or vinyl. In another embodiment, R 3 is bromo, hydroxy, methyl, methoxymethyl, cyclopropyl, or vinyl.

[0052] R 4 is optionally replaced by 1, 2, 3 or 4 which may be the same or different. 6 Preferably, R 4 is optionally replaced by 1, 2, or 3 which may be the same or different. 6 More preferably, R 4 is optionally replaced by 1 or 2 which may be the same or different from R 6 Even more preferably, R 4 is optionally represented by 2 which can be the same or different. 6 In one embodiment, R 4 is 3,4-dichlorophenyl, 3-chloro-4-cyano-phenyl, 4-cyano-3-fluoro-phenyl, 3-chloro-4-nitro-phenyl, or 3-fluoro-4-nitro-phenyl. In another embodiment, R 4 It is 3,4-dichlorophenyl.

[0053] R 5 is halogen, cyano, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 alkoxyC1-C6 alkyl, or nitro. Preferably, R 5is halogen, cyano, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C4 alkoxyC1-C3 alkyl, or nitro. More preferably, R 5 is halogen, cyano, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 haloalkoxy, C1-C3 alkoxyC1-C3 alkyl, or nitro. Even more preferably, R 5 is halogen, cyano, C1-C3 haloalkyl, or C1-C3 haloalkoxy. Still more preferably, R 5 is halogen, cyano, or C1-C3 haloalkyl. 5 is chloro, fluoro, cyano, trifluoromethyl, or trifluoromethoxy. 5 It is chloro, fluoro, cyano, or trifluoromethyl.

[0054] R 6 is cyano, nitro, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 alkoxy C1-C6 alkyl, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfonylamino, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 alkylaminocarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylaminocarbonyl, or N,N-di(C1-C4 alkyl)aminocarbonyl. Preferably, R 6 is cyano, nitro, halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C3 alkoxy C1-C3 alkyl, C1-C4 alkylsulfanyl, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 alkylsulfonylamino, C1-C4 alkylcarbonyl, C1-C4 alkoxycarbonyl, C1-C4 alkylaminocarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylaminocarbonyl, or N,N-di(C1-C3 alkyl)aminocarbonyl. More preferably, R 6 is cyano, nitro, halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C3 alkoxyC1-C3 alkyl, C1-C3 alkylsulfanyl, C1-C3 alkylsulfinyl, C1-C3 alkylsulfonyl, C1-C3 alkylsulfonylamino, C1-C3 alkylcarbonyl, C1-C3 alkoxycarbonyl, C1-C3 alkylaminocarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylaminocarbonyl, or N,N-di(C1-C3 alkyl)aminocarbonyl. Even more preferably, R 6is cyano, nitro, halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C3 alkoxyC1-C3 alkyl, C1-C3 alkylsulfanyl, C1-C3 alkylsulfonyl, C1-C2 alkylcarbonyl, C1-C3 alkoxycarbonyl, or N,N-di(C1-C2 alkyl)aminocarbonyl. In one embodiment, R 6 is cyano, nitro, or halogen, preferably cyano, nitro, fluorine, or chlorine. In another embodiment, R 6 is halogen, preferably chlorine.

[0055] Among the compounds of formula (I) according to the present invention, preferably:

[0056] R 1 is hydrogen, methyl, phenyl, phenyl C1-C2 alkyl, or pyridyl, and wherein the phenyl and pyridyl moieties are each optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented by is substituted;

[0057] R 2 is hydrogen or methyl;

[0058] R 3 is hydrogen, halogen, cyano, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, or C2-C6 alkynyl;

[0059] R 4 is optionally replaced by 1 or 2 which may be the same or different from R 6 The group represented by substituted phenyl;

[0060] R 5 is halogen, cyano, or trifluoromethyl; and

[0061] R 6 is cyano, nitro, or halogen.

[0062] In another set of embodiments,

[0063] R 1 is hydrogen, C1-C6 alkyl, phenyl, phenylC1-C2 alkyl, heteroaryl, or heteroarylC1-C2 alkyl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, and wherein the phenyl and heteroaryl moieties each may be optionally substituted by 1, 2 or 3 residues which may be the same or different and are represented by R 5 The group represented by is substituted;

[0064] R 2 It is methyl;

[0065] R3 is hydrogen, halogen, cyano, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, or C2-C6 alkynyl;

[0066] R 4 is 3,4-dichlorophenyl; and

[0067] R 5 is halogen, cyano, or trifluoromethyl.

[0068] In another set of embodiments,

[0069] R 1 is hydrogen, methyl, phenyl, phenylmethyl, or pyridyl, wherein the phenyl and pyridyl moieties may each be optionally replaced by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented by is substituted;

[0070] R 2 It is methyl;

[0071] R 3 is hydrogen, bromine, chlorine, hydroxy, methyl, ethyl, methoxymethyl, cyclopropyl, or vinyl;

[0072] R 4 is 3,4-dichlorophenyl; and

[0073] R 5 It is chloro, fluoro, cyano, or trifluoromethyl.

[0074] In another set of embodiments,

[0075] R 1 is methyl, phenyl, phenylmethyl, or pyridyl, wherein the phenyl and pyridyl moieties may each be optionally replaced by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented by is substituted;

[0076] R 2 It is methyl;

[0077] R 3 is hydrogen, halogen, cyano, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, or C2-C6 alkynyl;

[0078] R 4 is 3,4-dichlorophenyl; and

[0079] R 5 It is chloro, fluoro, cyano, or trifluoromethyl.

[0080] In another set of embodiments,

[0081] R 1 is methyl, phenyl, phenylmethyl, or pyridyl, wherein the phenyl and pyridyl moieties may each be optionally replaced by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented by is substituted;

[0082] R 2 It is methyl;

[0083] R 3 is bromine, chlorine, hydroxy, methyl, ethyl, methoxymethyl, cyclopropyl, or vinyl;

[0084] R 4 is 3,4-dichlorophenyl; and

[0085] R 5 It is chloro, fluoro, cyano, or trifluoromethyl.

[0086] The compounds of the present invention can be prepared as shown in the following schemes, wherein, unless otherwise stated, the definition of each variable is as defined above for compounds of formula (I). The following describes a general method for producing compounds of formula (I). Unless otherwise stated in the text, R 1 , R 2 , R 3 , R 4 , and R 5 is as defined above. The starting materials for preparing the compounds of the present invention can be purchased from common commodity suppliers or can be prepared by known methods. The starting materials and intermediates can be purified by prior art methods (such as chromatography, crystallization, distillation and filtration) before being used in the next step.

[0087] Scenario 1:

[0088]

[0089] The compound of formula (I) can be prepared by hydrolyzing a compound of formula A (wherein R 5 In the case of using a base, the product is obtained after acidification with a suitable acid such as hydrochloric acid. This is shown in Scheme 1 above.

[0090] Scenario 2:

[0091]

[0092] Compounds of formula A can be prepared from compounds of formula B (wherein X is Cl or Br) by metal-catalyzed cross-coupling reactions (such as Suzuki-Miyaura cross-coupling) under conditions similar to those in the literature. Typically, the reaction is carried out by reacting a compound of formula B with R in the presence of a suitable catalyst (such as bis(triphenylphosphine)palladium(II) chloride, tetrakis(triphenylphosphine)palladium, tris(dibenzylideneacetone)dipalladium, or (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) chloride dichloromethane adduct) or optionally palladium diacetate with a ligand (such as 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl), in the presence of a base (such as potassium carbonate or cesium carbonate, or tripotassium phosphate), in a suitable organic solvent (such as 1,4-dioxane, toluene or tetrahydrofuran), and optionally in the presence of water at elevated temperature. 3 -boric acid, boroxane or tetrafluoroborate. This is shown in Scheme 2 above.

[0093] Alternatively, a compound of formula A (wherein R 3 is cyano) can be prepared from compounds of formula B (wherein X is Cl or Br) by reaction with a suitable cyanating agent (such as copper cyanide) in a suitable solvent (such as N,N-dimethylformamide) at elevated temperature.

[0094] Scenario 3:

[0095]

[0096] In another transformation, a compound of formula A (wherein R 3 is C1-C6 alkyl) can be prepared from a compound having formula A (wherein R 3 is a C2-C6 alkenyl) by reacting with hydrogen in the presence of a suitable metal catalyst such as platinum (IV) oxide in a suitable solvent such as ethyl acetate at room temperature or at elevated temperature. This is shown in Scheme 3 above.

[0097] Solution 4:

[0098]

[0099] Compounds of formula B (wherein X is Cl, Br or I) can be prepared by treating a compound of formula C with a suitable halogenating agent (such as N-iodosuccinimide, N-bromosuccinimide or N-chlorosuccinimide), optionally in the presence of trifluoroacetic acid, in a suitable solvent (such as acetonitrile or dichloromethane), at room temperature or at an elevated temperature (such as 80° C.). This is shown in Scheme 4 above.

[0100] Solution 5:

[0101]

[0102] A compound having formula C (wherein R 1 is hydrogen) can be prepared from compounds of formula D wherein X is a halogen (eg, chlorine) by a metal-catalyzed cross-coupling reaction such as the Suzuki-Miyaura cross-coupling under conditions similar to those in the literature. Typically, the reaction is carried out by reacting a compound of formula D with R in the presence of a suitable catalyst (such as dichloro-(chloromethylchloroonium)-bis[cyclopentyl(diphenyl)phosphinium]palladium(3-); iron, bis(triphenylphosphine)palladium(II) dichloride, tetrakis(triphenylphosphine)palladium, tris(dibenzylideneacetone)dipalladium, or (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride dichloromethane adduct) or optionally palladium diacetate with a ligand (such as 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl), in the presence of a base (such as potassium carbonate or cesium carbonate, or tripotassium phosphate), in a suitable organic solvent (such as 1,4-dioxane, toluene or 2-methyltetrahydrofuran), and optionally in the presence of water at elevated temperature. 4 -boronic acid reaction. Compounds of formula D are commercially available or can be prepared by methods reported in the literature. This is shown in Scheme 5 above.

[0103] Solution 6:

[0104]

[0105] A compound having formula A (wherein R 1 is phenyl) can be made from a compound having formula A (wherein R 1 is hydrogen) by copper-catalyzed reaction with phenylboronic acid under Chan Lam conditions as reported in the literature. Typically, the reaction is carried out by reaction with an arylboronic acid in the presence of a base such as pyridine or triethylamine, in the presence of a catalyst such as copper(II) acetate, optionally in the presence of an oxidant (typically air) and an additive such as boric acid, in a suitable solvent such as acetonitrile, and at elevated temperature.

[0106] In a similar transformation, a compound of formula A (wherein R 1 is an alkyl group (eg, a methyl group) can be prepared from a compound having the formula A (wherein R 1 is hydrogen) by alkylation with a suitable alkylating agent such as methyl iodide in a suitable solvent such as N,N-dimethylformamide in the presence of a base such as cesium carbonate and also in the presence of a lithium salt such as lithium chloride. This is shown in Scheme 6 above.

[0107] Solution 7:

[0108]

[0109] Alternatively, compounds of formula (I) can be prepared by reacting a compound of formula E with a compound of formula F in a suitable solvent (such as N,N-dimethylformamide) at elevated temperatures, followed by reaction with scandium trifluoromethanesulfonate at room temperature. Compounds of formula F are commercially available or can be prepared by methods reported in the literature. Compounds of formula E can be prepared by methods reported in the literature. This is shown in Scheme 7 above.

[0110] The present invention further provides a method for controlling weeds at a site, the method comprising applying a composition comprising a compound of formula (I) to the site in an amount of weed control. In addition, the present invention may further provide a method for selectively controlling weeds at a site including useful (crop) plants and weeds, wherein the method comprises applying a composition according to the present invention in an amount of weed control to the site. 'Control' means killing, reducing or delaying growth or preventing or reducing germination. It should be noted that the compounds of the present invention show greatly improved selectivity compared to known structurally similar compounds. Typically, the plants to be controlled are unwanted plants (weeds). 'Site' means the area where the plant is growing or will grow. Application can be applied to the site before and / or after the emergence of the crop plant. Preferably, the compound of the present invention is applied to the site after the emergence of the crop. Some crop plants can inherently tolerate the herbicidal action of the compound of formula (I).

[0111] The application rate of the compound of formula (I) can vary within wide limits and depends on the nature of the soil, the method of application (pre-emergence or post-emergence; seed dressing; application to the seed furrow; no-till application, etc.), the crop plants, one or more weeds to be controlled, the prevailing climatic conditions and other factors governed by the method of application, the time of application and the target crop. The compound of formula I according to the invention is usually applied at a rate of 10 g / ha to 2500 g / ha, especially 25 g / ha to 1000 g / ha, more especially 25 g / ha to 250 g / ha.

[0112] Application is usually carried out by spraying the composition, typically by means of a tractor-mounted sprayer for large areas, but other methods such as dusting (for powders), dripping or drenching may also be used.

[0113] The term "useful plants" is to be understood as also including useful plants which have been rendered tolerant to herbicides such as bromoxynil or classes of herbicides such as, for example, 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, ALS inhibitors such as primisulfuron, primisulfuron and trifloxysulfuron, 5-enol-pyruvyl-shikimate-3-phosphate-synthase (EPSPS) inhibitors, glutamine synthetase (GS) inhibitors or protoporphyrinogen oxidase (PPO) inhibitors as a result of conventional breeding methods or genetic engineering. Examples of crops which have been rendered tolerant to imidazolinones such as imazamox by conventional breeding methods (mutagenesis) are Summer rapeseed (canola). Examples of crops that have been rendered tolerant to herbicides or herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties, which are Herculex and Commercially available under the trade name ANTIQUID®.

[0114] The term "useful plants" is to be understood as also including useful plants which have been transformed by the use of recombinant DNA techniques in such a way that they are able to synthesize one or more selectively acting toxins, as are known, for example, from toxigenic bacteria, in particular those of the genus Bacillus.

[0115] Examples of such plants are: (maize variety expressing CryIA(b) toxin); YieldGard (maize variety expressing CryIIIB(b1) toxin); YieldGard (maize varieties expressing CryIA(b) and CryIIIB(b1) toxins); (maize variety expressing Cry9(c) toxin); Herculex (maize variety expressing the CryIF(a2) toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) that confers tolerance to the herbicide glufosinate ammonium); NuCOTN (cotton variety, expressing CryIA(c) toxin); (cotton variety expressing CryIA(c) toxin); Bollgard (cotton varieties expressing CryIA (c) and CryIIA (b) toxins); (cotton varieties expressing VIP toxin); (potato variety, expressing CryIIIA toxin); GT Advantage (GA21 glyphosate tolerance trait), CB Advantage (Bt11 corn borer (CB) trait), RW (corn rootworm trait) and

[0116] Plant crops or their seed material can be both resistant to herbicides and at the same time resistant to insect feeding ("stacked" transgenic events). For example, seeds can have the ability to express an insecticidal Cry3 protein while being tolerant to glyphosate.

[0117] Crop plants are also to be understood as including those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (eg improved storage stability, higher nutritional value and improved flavor).

[0118] The compounds of formula (I) (or compositions comprising them) can be used to control unwanted plants (collectively referred to as 'weeds'). The weeds to be controlled may be monocotyledonous species, for example Agrostis, Alopecurus, Avena, Brachiaria, Bromus, Cenchrus, Cyperus, Digitaria, Echinochloa, Eleusine, Lolium, Monochoria, Rottboellia, Sagittaria, Scirpus, Setaria, a) and Sorghum, and also dicotyledonous species, such as Abutilon, Amaranthus, Ambrosia, Chenopodium, Chrysanthemum, Conyza, Galium, Ipomoea, Nasturtium, Sida, Sinapis, Solanum, Stellaria, Veronica, Viola and Xanthium.

[0119] The compounds of formula (I) can be used in unmodified form or preferably together with adjuvants conventionally used in the field of formulation to provide herbicidal compositions, using formulation adjuvants, such as carriers, solvents and surfactants (SAAs). Therefore, the present invention further provides a herbicidal composition comprising at least one compound of formula (I) and an agriculturally acceptable carrier and optionally an adjuvant. An agriculturally acceptable carrier is, for example, a carrier suitable for agricultural use. Agricultural carriers are well known in the art.

[0120] The herbicidal compositions generally comprise 0.1 to 99% by weight, in particular 0.1 to 95% by weight, of compounds of formula (I) and 1 to 99.9% by weight of formulation adjuvants which preferably comprise 0 to 25% by weight of surface-active substances.

[0121] The composition can be selected from a number of formulation types. These include emulsion concentrates (EC), suspension concentrates (SC), suspoemulsions (SE), capsule suspensions (CS), water dispersible granules (WG), emulsifiable granules (EG), water-in-oil emulsions (EO), oil-in-water emulsions (EW), microemulsions (ME), oil dispersions (OD), oil suspensions (OF), oil-soluble liquids (OL), soluble concentrates (SL), ultra-low volume suspensions (SU), ultra-low volume liquids (UL), master drugs (TK), dispersible concentrates (DC), soluble powders (SP), wettable powders (WP) and soluble granules (SG). In any case, the formulation type selected will depend on the specific purpose envisioned and the physical, chemical and biological properties of the compound of formula (I).

[0122] Soluble powders (SP) can be prepared by mixing a compound of formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulfate) or one or more water-soluble organic solids (such as polysaccharides) and optionally one or more wetting agents, one or more dispersants or mixtures of said agents to improve water dispersibility / water solubility. The mixture is then ground into a fine powder. Similar compositions can also be granulated to form water-soluble granules (SG).

[0123] Wettable powders (WP) can be prepared by mixing a compound of formula (I) with one or more solid diluents or carriers, one or more wetting agents and preferably one or more dispersants, and optionally one or more suspending agents to facilitate dispersion in a liquid. The mixture is then ground into a fine powder. Similar compositions can also be granulated to form water dispersible granules (WG).

[0124] Granules (GR) may be formed by granulating a mixture of a compound of formula (I) and one or more powdered solid diluents or carriers, or by absorbing the compound of formula (I) (or a solution thereof in a suitable agent) into a porous granular material such as pumice, attapulgite clay, Fuller's earth, kieselguhr, diatomaceous earth or corn cob meal, or by adsorbing the compound of formula (I) (or a solution thereof in a suitable agent) onto a hard core material such as sand, silicates, mineral carbonates, sulfates or phosphates and drying if necessary. Agents commonly used to aid absorption or adsorption include solvents such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters and adhesives such as polyvinyl acetate, polyvinyl alcohol, dextrins, sugars and vegetable oils. One or more other additives such as emulsifiers, wetting agents or dispersants may also be included in the granules.

[0125] Dispersible concentrates (DC) can be prepared by dissolving a compound of formula (I) in water or an organic solvent such as a ketone, alcohol or glycol ether. These solutions may contain a surfactant (for example to improve water dilution or to prevent crystallization in a spray tank).

[0126] Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) can be prepared by dissolving a compound of formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifiers or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a registered trademark), ketones (such as cyclohexanone or methylcyclohexanone) and alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkylpyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethylamides of fatty acids (such as C8-C 10 EC products emulsify spontaneously when added to water, producing an emulsion with sufficient stability to allow spray application by appropriate equipment.

[0127] The preparation of EWs involves obtaining a compound of formula (I) as a liquid (if it is not liquid at room temperature, it can be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in a suitable solvent), and then emulsifying the resulting liquid or solution into water containing one or more SAAs under high shear to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzene), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other suitable organic solvents having low solubility in water.

[0128] Microemulsions (ME) can be prepared by mixing water with a blend of one or more solvents and one or more SAAs to spontaneously produce a thermodynamically stable, isotropic liquid formulation. The compound of formula (I) is initially present in water or in a solvent / SAA blend. Suitable solvents for use in MEs include those described above for use in ECs or EWs. MEs can be oil-in-water systems or water-in-oil systems (which system is present can be determined by conductivity measurements) and can be suitable for mixing water-soluble pesticides and oil-soluble pesticides in the same formulation. MEs are suitable for dilution into water, remaining as microemulsions or forming conventional oil-in-water emulsions.

[0129] Suspension concentrates (SC) may include aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula (I). SC may be prepared by ball milling or bead milling a solid compound of formula (I) with one or more dispersants in a suitable medium to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition, and a suspending agent may be included to reduce the rate of particle settling. Alternatively, a compound of formula (I) may be dry-milled and added to water containing the reagents described above to produce a desired final product.

[0130] Aerosol formulations comprise a compound of formula (I) and a suitable propellant (e.g. n-butane). The compound of formula (I) may also be dissolved or dispersed in a suitable medium (e.g. water or a water-miscible liquid such as n-propanol) to provide a composition for use in a non-pressurized hand-operated spray pump.

[0131] Capsule suspensions (CS) can be prepared in a similar manner to the preparation of EW formulations, but with an additional polymerization stage, to obtain an aqueous dispersion of oil droplets, each of which is wrapped by a polymer shell and contains a compound of formula (I) and optionally a carrier or diluent for the oil droplet. The polymer shell can be produced by an interfacial polycondensation reaction or by a coacervation procedure. These compositions can provide controlled release of compounds of formula (I) and they can be used for seed treatment. Compounds of formula (I) can also be formulated in a biodegradable polymer matrix to provide slow, controlled release of the compound.

[0132] The composition may include one or more additives to improve the biological performance of the composition, for example by improving wettability, retention or distribution on a surface; rain resistance on a treated surface; or absorption or mobility of a compound of formula (I). Such additives include surfactants (SAAs), oil-based spray additives such as certain mineral oils or natural vegetable oils (such as soybean and rapeseed oils), modified vegetable oils (such as methylated rapeseed oil (MRSO)), and blends of these with other bioenhancement adjuvants (ingredients that can assist or modify the action of a compound of formula (I)).

[0133] The wetting agent, dispersant and emulsifier may be a cationic type, anionic type, amphoteric type or nonionic type SAA.

[0134] Suitable cationic-type SAAs include quaternary ammonium compounds (eg, cetyltrimethylammonium bromide), imidazolines, and amine salts.

[0135] Suitable anionic SAAs include alkali metal salts of fatty acids, salts of aliphatic monoesters of sulfuric acid (e.g. sodium lauryl sulfate), salts of sulfonated aromatic compounds (e.g. sodium dodecylbenzenesulfonate, calcium dodecylbenzenesulfonate, butylnaphthalenesulfonate and mixtures of sodium di-isopropyl-naphthalenesulfonate and sodium tri-isopropyl-naphthalenesulfonate), ether sulfates, alcohol ether sulfates (e.g. sodium laureth-3-sulfate), ether carboxylates (e.g. sodium laureth-3-carboxylate), phosphates (products from the reaction of one or more fatty alcohols with phosphoric acid (mainly monoesters) or with phosphorus pentoxide (mainly diesters), for example the reaction of lauryl alcohol with tetraphosphoric acid; additionally, these products may be ethoxylated), sulfosuccinamates, paraffin or olefin sulfonates, taurates, lignin sulfonates and phosphates / sulfates of tristyrylphenol.

[0136] Suitable amphoteric types of SAA include betaine, propionate and glycinate.

[0137] Suitable SAAs of the nonionic type include condensation products of alkylene oxides (such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof) with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long-chain fatty acids or hexitol anhydrides; condensation products of the partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; monoesters (such as fatty acid polyethylene glycol esters); amine oxides (such as lauryl dimethyl amine oxide); lecithin and sorbitan and its esters, alkyl polyglycosides and tristyrylphenol.

[0138] Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinyl pyrrolidone or sodium carboxymethyl cellulose) and swelling clays (such as bentonite or attapulgite).

[0139] The compounds of the present invention may also be used in admixture with one or more additional herbicides and / or plant growth regulators. Examples of such additional herbicides or plant growth regulators include acetochlor, acifluorfen (including acifluorfen sodium), bensulfuron, ametryn, amitriptyline, aminopyralid, cypermethrin, atrazine, flubutyric acid-M, quinclorac, bensulfuron-methyl (including bensulfuron-methyl), bentazone, flupyralid, bialaphos, bispyribac, bispyribac-sodium, bixlozone, broclozone, herbicide, bromoxynil, butachlor, flupyralid, fenpyridone (including fenpyridone-ethyl), chlorsulfuron (including chlorsulfuron-methyl), chlorsulfuron (including chlorsulfuron-ethyl), Chlorotoluron, chlorsulfuron, cyproconazole, clacyfos, clethodim, clodinafop-butyl (including clodinafop-butyl), clomazone, clopyralid, cyclopyranil, cyclopyrimorate, cyprosulfuron, cyhalofop-butyl (including cyhalofop-butyl-butyl), 2,4-D (including its choline salt and 2-ethylhexyl ester), 2,4-DB, betaine, dicamba (including its aluminum, aminopropyl, bis-aminopropylmethyl, choline, 2,4-dichloropropionic acid, diethylene glycolamine, dimethylamine, dimethylammonium, potassium and sodium salts), bisclostrobin, fluazifop-butyl, fluazifop-butyl, dimethoate, pyridazine dioxopyritrione, dibromodiquat, diuron, epyrifenacil, ethylbutenefluanid, ethylfuran, oxazolidinone (including oxazolidinone-ethyl), fenoxasulfone, fenpyrazone, fenquinotrione, tetrazoline, fluazifop, bispyribac, florpyrauxifen (including florpyrauxifen-benzyl), fluazifop (including fluorine fluazifop-butyl), fluchloraminopyr (including fluchloraminopyr) (including fluchloraminopyr) Fluchloramino-tefuryl), flufenacet, flufenoximacil, fluazifop, fluazifop-butyl, fluazifop-butyl, fluazifop-butyl, fluazifop-butyl (including fluazifop-methyl-sodium), fluroxypyr (including fluroxypyr-meptyl), flusulfuron, flufenoximacil, foramsulfuron, glufosinate (including L-glufosinate and ammonium salts of both), glyphosate (including its hydrazine, isopropyl ammonium and potassium salts), halauxifen (including halauxifen-methyl), haloxalothioate (including haloxalothioate-methyl), hexazinone,Hydantocidin, icafolin (including icafolin-methyl), imazamox (including R-imazamox), imazapic, imazapic, imazapic, indolepyr (including indolauxipyr-butyl), iodosulfuron (including iodosulfuron-methyl-sodium), iofensulfuron (including iofensulfuron-sodium), ioboxynil, iptriazopyrid, isoproturon, isoxathiapiprolin, lancotrione, MCPA, MCPB, mecoprop- P), mesotrione (including mesotrione-methyl), mesotrione, metamitron, metazachlor, isothiozolin, isopropylamine, sulfamethoxazole, metribuzin, metsulfuron, propamide, nicosulfuron, norchlor, oxadiazine, oxasulfuron, oxyfluorfen, paraquat dichloride, pendimethalin, penoxsulam, bendisulfuron, picloram, pinoxaden, pretilachlor, primisulfuron-methyl, promethazine, propanil, oxadiazine, propyrisulfuron, propyrisulfuron, promethazine, procarb, prosulfuron, pyraflufen, pyraflufen (including pyraflufen-ethyl), pyraquinate, sulfamethoxazole Pyrazole, pyridazine, pyriflubenzoxim, pyrimisulfan, pyroxilsulfuron, formosulfuron, quinclorac, clomeclorac, quizalofop-ethyl (including quizalofop-P-tefuryl), rimisoxafen, sulfamethoxam, pyriflubenzoxim, sethoxydim, simazine, S-isopropylamine, sulfamethoxam, sulfamethoxam, sulfamethoxam, thiosulfuron, thiosulfuron, tetthiocarb, tetthiocarb, terbuthion, terbutaline, tetflupyrolimet, thiencarbazone, thifensulfuron, fluazifop-ethyl tiafenacil, tolpyralate, benzylpyrazone, trimethoprim, triafamone, wild wheat chlorpyrifos, bensulfuron-methyl, bensulfuron-methyl (including bensulfuron-methyl), triclopyr, trifloxysulfuron (including trifloxysulfuron-sodium), trifluoxazin, flufenac, flufenac, triazosulfuron, 3-(2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylic acid ethyl ester, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one,4-Hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridinyl]imidazolidin-2-one, 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridinyl]imidazolidin-2-one, 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridinyl]imidazolidin-2-one, 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl] Imidazolidin-2-one, (4R) 1-(5-tert-butylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one, (1RS,5SR)-3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-yl methyl carbonate, ethyl-2-[[3-[[3-chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-( 2-[2-[2-bromo-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy]phenoxy]-2-methoxy-acetic acid methyl ester, 6-chloro-4-(2,7-dimethyl-1-naphthyl)-5-hydroxy-2-methyl-pyridazin-3-one, 6-amino-5-chloro-2-(4-chloro-2-fluoro-3-methoxy -phenyl)pyrimidine-4-carboxylic acid (2-fluorophenyl)methyl ester, 6-amino-5-chloro-2-(4-chloro-2-fluoro-3-methoxy-phenyl)pyrimidine-4-carboxylic acid, and 3-[2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluorophenyl]-3a,4,5,6-tetrahydro-6-methyl-6a-cyclopenta[d]isoxazole-6a-carboxylic acid methyl ester.

[0140] The mixing partners of the compounds of formula (I) can also be in the form of esters or salts, as mentioned, for example, in The Pesticide Manual, 19th edition, British Crop Protection Council, 2021. The mixing ratio of the compound of formula (I) to the mixing partner is preferably 1:100 to 1000:1.

[0141] These mixtures can advantageously be used in the abovementioned formulations (in this case, "active ingredient" relates to the corresponding mixture of the compound of formula (I) with the mixing partner).

[0142] The compounds or mixtures of the present invention can also be used in combination with one or more herbicide safeners. Examples of such safeners include cloquintocet, cloquintocet (including cloquintocet-mexyl), cyclopropylsulfonamide, dichloropropene, oxadiazole (including oxadiazole ethyl), chlorpyrifos, fluazifop, oxadiazole, isoxadiazole (including isoxadiazole-ethyl), mefenpyr (including mefenpyr-butyl), metcamifen and oxadiazole.

[0143] Particularly preferred are mixtures of compounds of formula (I) with cyprosulfamide, isoxadifen-ethyl, clofonet-mexyl and / or sulfamethoxazole.

[0144] The safener of the compound of formula (I) may also be in the form of an ester or salt, as mentioned, for example, in The Pesticide Manual, 19th edition (BCPC), 2021. References to clofonethiol also apply to its lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts, as disclosed in WO 02 / 34048.

[0145] Preferably, the mixing ratio of compound of formula (I) to safener is from 100:1 to 1:10, in particular from 20:1 to 1:1.

[0146] Compounds of formula (I) are usually used in the form of agrochemical compositions and can be applied to crop areas or plants to be treated simultaneously or sequentially with other compounds. For example, these other compounds can be fertilizers or micronutrient donors or other preparations that affect plant growth. They can also be selective herbicides or non-selective herbicides, as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with other carriers, surfactants or adjuvants that are commonly used in the formulation field to promote application.

[0147] As used herein, the term "locus" means a place where or on which plants grow, or where seeds of cultivated plants are sown, or where seeds are to be placed in the soil. It includes soil, seeds and seedlings, as well as established vegetation.

[0148] The term "plant" refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, leaves, and fruits.

[0149] The term "plant propagation material" should be understood as meaning the reproductive parts of a plant, such as seeds, which can be used for the propagation of a plant, and vegetative materials, such as cuttings or tubers (e.g., potatoes). For example, seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes, and parts of plants can be mentioned. Germinated plants and young plants that will be transplanted after germination from the soil or after emergence can also be mentioned. These young plants can be protected before transplanting by being treated completely or partially by dipping. Preferably, "plant propagation material" should be understood as meaning seeds.

[0150] The pesticides referred to herein using their common names are known, for example, from “The Pesticide Manual”, 19th edition, British Crop Protection Council 2021.

[0151] Compounds with formula (I) can be used in unmodified form, or preferably, together with conventional adjuvants used in the formulation field. For this purpose, they can be conveniently formulated as emulsifiable concentrates, pastes that can be coated, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granules and also encapsulations, for example in polymeric substances, in a known manner. For the type of composition, according to the intended purpose and the environment at that time, the application method is selected, such as spraying, atomizing, dusting, sowing, coating or watering. Compositions can also contain other adjuvants, such as stabilizers, defoamers, viscosity modifiers, adhesives or tackifiers, and fertilizers, micronutrient donors or other formulations for obtaining special effects.

[0152] Suitable carriers and adjuvants, for example for agricultural use, may be solid or liquid and are substances useful in formulation technology, such as natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, adhesives or fertilizers. Such carriers are for example described in WO 97 / 33890.

[0153] The compounds of formula (I) are usually used in the form of compositions and can be applied to crop areas or plants to be treated simultaneously or sequentially with other compounds. For example, these other compounds can be fertilizers or micronutrient donors or other preparations that affect plant growth. They can also be selective herbicides or non-selective herbicides, as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with other carriers, surfactants or adjuvants that are commonly used in the formulation field to promote application.

[0154] The compound of formula (I) can be the sole active ingredient of the composition, or it can be mixed with one or more additional active ingredients (such as pesticides, fungicides, synergists, herbicides or plant growth regulators) when appropriate. In some cases, the additional active ingredients can produce unexpected synergistic activity.

[0155] Typically, the formulation comprises 0.01% to 90% by weight of an active agent, 0% to 20% of an agriculturally acceptable surfactant and 10% to 99.99% of a solid or liquid formulation inert agent and one or more adjuvants, the active agent being at least composed of a compound with formula (I) together with components (B) and (C), and optionally other active agents (particularly microbicides or preservatives or the like). The concentrated form of the composition typically contains between about 2% and 80% by weight, preferably between about 5% and 70% of the active agent. The application form of the formulation can, for example, contain 0.01% to 20% by weight, preferably 0.01% to 5% by weight of the active agent. However, commercial products will preferably be formulated as concentrates, and end users will typically use diluted formulations.

[0156] The following table shows examples of individual compounds of formula (I) according to the invention:

[0157]

[0158] Table 1: Individual compounds of formula (I) according to the invention

[0159]

[0160]

[0161]

[0162] Table A-1 provides 52 compounds A-1.001 to A.1.052 having formula (I), wherein R 1 , R 2 , R 3 and R 4 As defined in Table 1.

[0163] Preparation Examples

[0164]

[0165] The active ingredient is mixed thoroughly with the adjuvant and the mixture is ground thoroughly in a suitable grinder to provide a wettable powder which can be diluted with water to give a suspension of the desired concentration.

[0166]

[0167] The active ingredient is mixed thoroughly with the adjuvant and the mixture is thoroughly ground in a suitable grinder to provide a dust that can be used directly for seed treatment.

[0168] Emulsifiable concentrates

[0169]

[0170] Emulsions of any desired dilution which can be used in plant protection can be obtained from these concentrates by dilution with water.

[0171]

[0172] Ready-to-use dusts are obtained by mixing the active ingredient with a carrier and grinding the mixture in a suitable grinder. Such dusts can also be used for dry seed dressing of seeds.

[0173] Extruder pellets

[0174]

[0175] The active ingredient is mixed with the auxiliary agent and ground, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

[0176] Coated granules

[0177] Active ingredient [compound of formula (I)] 8%

[0178] Polyethylene glycol (mol weight 200) 3%

[0179] Kaolin 89%

[0180] The finely ground active ingredient is applied uniformly in a mixer to the kaolin moistened with polyethylene glycol. In this way, dust-free coated granules are obtained.

[0181] Suspension concentrates

[0182]

[0183] The finely ground active ingredient is intimately mixed with the adjuvant to give a suspension concentrate from which suspension concentrates of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants and plant propagation materials can be treated and protected against microbial infestation by spraying, pouring or immersion.

[0184] Flowable concentrate for seed treatment

[0185]

[0186] The finely ground active ingredient is intimately mixed with the adjuvant to give a suspension concentrate from which suspension concentrates of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants and plant propagation materials can be treated and protected against microbial infestation by spraying, pouring or immersion.

[0187] Extended-release capsule suspension

[0188] 28 parts of a combination of compounds of formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of a toluene diisocyanate / polymethylene-polyphenyl isocyanate mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinyl alcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is reached. To this emulsion is added a mixture of 2.8 parts of 1,6-hexanediamine in 5.3 parts of water. The mixture is stirred until the polymerization reaction is complete. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersant. The capsule suspension formulation contains 28% of active ingredient. The diameter of the medium capsules is 8-15 microns. The resulting formulation is applied to the seeds as an aqueous suspension in an apparatus suitable for this purpose.

[0189] Examples

[0190] The following non-limiting examples provide specific synthetic methods for representative compounds of the present invention (as mentioned in Table 2 below).

[0191] Throughout this specification, temperatures are given in degrees Celsius (° C.) and “mp” means melting point. LC / MS means liquid chromatography mass spectrometry, and a description of the apparatus and methods is as follows:

[0192] Shimadzu LC-MS2020, using Sample Organizer with SPD-M40 PDA. Mass spectrometer-ionization method: electrospray (ESI), polarity: positive and negative ions, heating block temperature (°C) 400, DL temperature (°C) 250, nebulizing gas flow rate (L / min) 1.5. Instrument equipped with HALO C18 column (column length 30 mm, column inner diameter 3.0 mm, particle size 2.7 microns). Gradient elution: 5%-95% MeCN in water in 2.5 min at 1.5 ml / min. Both MeCN and water contain 0.05% v / v FA.

[0193] List of abbreviations

[0194] brm = broad multiplet, brd = broad doublet, brs = broad singlet, °C = degrees Celsius, d = doublet, dd = double of doublet, ddd = double of doublet, DMSO = dimethyl sulfoxide, HPLC = high performance liquid chromatography, LCMS = liquid chromatography mass spectrometry, M = mole, m = multiplet, MHz = megahertz, q = quartet, s = singlet, t = triplet.

[0195] Example 1: Synthesis of 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (Compound 1)

[0196] Step 1: Synthesis of ethyl 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate

[0197]

[0198] To a solution of ethyl 4-chloro-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.100 g, 0.46 mmol) and (3,4-dichlorophenyl)boronic acid (0.097 g, 0.51 mmol) in a mixture of 2-methyltetrahydrofuran (2.0 mL) and water (0.37 mL) was added tripotassium phosphate (0.30 g, 1.39 mmol). The mixture was heated to dissolve the potassium phosphate. The mixture was degassed under a stream of nitrogen for 15 minutes. Dichloro-(chloromethylchloroium)-bis[cyclopentyl(diphenyl)phosphinium]palladium(3-);iron (0.038 g, 0.046 mmol) was added thereto and the reaction mixture was heated at 80°C for 18 hours with stirring. The cooled reaction mixture was diluted with ethyl acetate (10 mL) and water (10 mL), and the phases were separated. The aqueous phase was extracted twice into ethyl acetate (2×10 mL). The combined organic phases were washed with brine and concentrated under reduced pressure to give a brown solid. This solid was purified by mass directed reverse phase HPLC to give ethyl 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.090 g, 0.27 mmol) as a brown solid.

[0199] 1 H NMR (400 MHz, chloroform) δ = 7.49 (d, 2H), 7.25 (brd, 1H), 6.05 (brs, 1H), 4.19 (q, 2H), 2.39 (s, 3H), 1.12 (t, 3H)

[0200] Step 2: Synthesis of ethyl 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate

[0201]

[0202] A solution of 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.100g, 0.31mmol) in dichloromethane (1.0mL) was cooled to 0 ° C under nitrogen. The reaction mixture was cooled to 0 ° C, and 1-bromopyrrolidine-2,5-dione (0.055g, 0.31mmol) was added. The reaction mixture was stirred at room temperature under a nitrogen atmosphere for 18 hours. The reaction mixture was concentrated under reduced pressure to obtain a brown solid, which was purified by flash silica gel chromatography using ethyl acetate with a gradient of 5%-100% in cyclohexane as eluent to obtain 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.12g, 0.30mmol) as a white solid.

[0203] 1 H NMR (400 MHz, chloroform) δ=13.48-12.92 (brm, 1H), 7.51 (d, 1H), 7.35 (s, 1H), 7.08 (dd, 1H), 4.08 (q, 2H), 2.56 (s, 3H), 1.00 (t, 3H)

[0204] Step 3: Synthesis of 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid

[0205]

[0206] To the solution of 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-ethyl formate (0.11g, 0.27mmol) in ethanol (4mL), add lithium hydroxide (0.013g, 0.30mmol) in water (1.1mL).The reaction mixture is stirred at room temperature for 18 hours.Additionally, lithium hydroxide (0.013g, 0.30mmol) in water (1.1mL) is added, and the reaction mixture is heated under reflux for 18 hours.The reaction mixture is quenched by adding saturated ammonium chloride aqueous solution and extracted into ethyl acetate.By adding hydrogen chloride aqueous solution (2M), the aqueous phase is acidified to pH 1, and each phase is separated.The aqueous phase is further extracted into ethyl acetate (30mL). The combined organic extracts were evaporated under reduced pressure to give a white solid which was purified by mass directed reverse phase HPLC to give 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (0.013 g, 0.035 mmol).

[0207] 1H NMR (400MHz, DMSO-d6)δ=7.71(d,1H),7.44(s,1H),7.15(d,1H),2.45(s,3H)

[0208] Example 2: Synthesis of 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (Compound 2)

[0209] Step 1: Synthesis of ethyl 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate

[0210]

[0211] To a solution of ethyl 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.163 g, 0.500 mmol) in dichloromethane (5 mL) was added 1-chloropyrrolidine-2,5-dione (0.067 g, 0.500 mmol) under a nitrogen atmosphere and at 0°C. The reaction mixture was stirred at room temperature for 14 days. The reaction mixture was evaporated to dryness under reduced pressure to give a paste solid, which was purified by mass-directed reverse phase HPLC to give ethyl 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.094 g, 0.26 mmol) as a paste solid.

[0212] 1 H NMR (500 MHz, chloroform) δ=7.51 (d, 1H), 7.34 (s, 1H), 7.08 (dd, 1H), 4.20-3.98 (m, 2H), 2.54 (s, 3H), 0.97 (t, 3H)

[0213] Step 2: Synthesis of 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid

[0214]

[0215] At room temperature, lithium hydroxide (0.053g, 2.22mmol) was added once to a stirred mixture of 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.160g, 0.444mmol) in a mixture of tetrahydrofuran and water (4.00mL, 1:1). The resulting mixture was heated at 65 ° C for 2 hours under stirring. The cooled reaction mixture was evaporated to dryness under reduced pressure. The residue was diluted with water and acidified to pH 1 by adding aqueous hydrogen chloride solution (2M) to obtain a precipitation of a white solid. The solid was filtered, washed with water (10mL) and dried to obtain 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (0.110g, 0.33mmol) as a white solid.

[0216] 1 H NMR (400MHz, DMSO-d6)δ=7.72(d,1H),7.49(d,1H),7.19(dd,1H),2.42(s,3H)

[0217] Example 3: Synthesis of 5-chloro-1-(4-chlorophenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 3)

[0218] Step 1: Synthesis of 5-chloro-1-(4-chlorophenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid ethyl ester

[0219]

[0220] To (4-chlorophenyl)boronic acid (0.035 g, 0.22 mmol), ethyl 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.040 g, 0.11 mmol), pyridine (0.017 g, 0.19 mmol), copper (II) acetate (0.042 g, 0.22 mmol), boric acid (0.0069 g, 0.11 mmol) and In the mixture of molecular sieves (0.0027g), acetonitrile (2.2mL) is added. Compressed air is bubbled through the reaction mixture heated to 50°C for 18 hours. Add another portion of (4-chlorophenyl) boronic acid (0.035g, 0.22mmol) and continue heating at 50°C until LCMS shows the consumption of starting material. The reaction mixture is diluted with aqueous hydrogen chloride solution (2M, 10mL) and ethyl acetate (10mL), and each phase is separated. The aqueous phase is extracted into ethyl acetate. The combined organic extracts are washed with saturated sodium bicarbonate aqueous solution (15mL) and brine (15mL), and evaporated to dryness under reduced pressure to obtain a brown oil, which is purified by mass-oriented reversed-phase HPLC to obtain 5-chloro-1-(4-chlorophenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid ethyl ester (0.012g, 0.026mmol).

[0221] 1 H NMR (400 MHz, chloroform) δ=7.53 (d, 1H), 7.43 (d, 1H), 7.37-7.32 (m, 3H), 7.13-7.08 (m, 2H), 4.12 (q, 2H), 2.50 (s, 3H), 1.06 (t, 3H)

[0222] Step 2: Synthesis of 5-chloro-1-(4-chlorophenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0223]

[0224] Prepared as described for 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid from 5-chloro-1-(4-chlorophenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid ethyl ester (0.012 g, 0.025 mmol) and lithium hydroxide (0.0021 g, 0.051 mmol) at room temperature to give 5-chloro-1-(4-chlorophenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.012 g, 0.025 mmol).

[0225] 1 H NMR (400 MHz, chloroform) δ=7.55-7.52 (m, 1H), 7.44 (d, 1H), 7.38-7.34 (m, 2H), 7.20-7.15 (m, 1H), 7.12 (d, 2H), 2.51 (s, 3H)

[0226] Example 4: Synthesis of 5-chloro-4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-pyridine-3-carboxylic acid (Compound 4)

[0227] Step 1: Synthesis of 5-chloro-4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-pyridine-3-carboxylic acid ethyl ester

[0228]

[0229] To a solution of 5-chloro-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.300 g, 0.832 mmol) in N,N-dimethylformamide (anhydrous, 5 mL) was added cesium carbonate (0.175 g, 2.08 mmol) and lithium chloride (0.106 g, 2.5 mmol), followed by addition of iodomethane (0.236 g, 1.66 mmol) in portions. The reaction mixture was heated at 45 ° C for 3 hours with stirring. The reaction mixture was diluted with water (30 mL) and extracted into ethyl acetate (3×15 mL). The combined organic extracts were evaporated to dryness under reduced pressure. The crude product was purified by silica gel chromatography using a gradient of 0% to 70% ethyl acetate in petroleum ether as eluent to afford ethyl 5-chloro-4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylate (100 mg, 0.27 mmol) as a white solid.

[0230] 1 H NMR (400MHz, DMSO-d6)δ=7.76(d,1H),7.53(d,1H),7.25(dd,1H),3.96(d,2H),3.57(s,3H),2.58(s,3H),0.89(t,3H)

[0231] Step 2: Synthesis of 5-chloro-4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-pyridine-3-carboxylic acid

[0232]

[0233] To a stirred solution of 5-chloro-4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-pyridine-3-carboxylic acid ethyl ester (0.080g, 0.214mmol) in a mixture of methanol (1.5mL) and water (1.5mL), lithium hydroxide (0.0153g, 0.641mmol) was added. The reaction mixture was heated at 65°C for 18 hours. The cooled reaction mixture was evaporated to dryness under reduced pressure, and the residue was diluted with water and acidified to pH 1 by adding aqueous hydrogen chloride solution (2M). The precipitated solid was filtered and washed with water and then purified by preparative HPLC to obtain 5-chloro-4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid (25.4mg, 0.073mmol) as a white solid.

[0234] 1 H NMR (400MHz, DMSO-d6) δ = 13.57 (brs, 1H), 7.74 (d, J = 8.4Hz, 1H), 7.51 (d, 1H), 7.22 (dd, 1H), 3.62 (s, 3H), 2.60 (s, 3H)

[0235] Example 5: Synthesis of 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-vinyl-1H-pyridine-3-carboxylic acid (Compound 8)

[0236] Step 1: Synthesis of ethyl 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-vinyl-1,2-dihydropyridine-3-carboxylate

[0237]

[0238] Potassium hydride trifluoro(vinyl)boron (1.71 g, 12.8 mmol), dicesium carbonate (4.99 g, 15.3 mmol) and [1,1'-bis(diphenylphenylphosphino)ferrocene]dichloropalladium(II) (0.373 g, 0.510 mmol) were added to a stirred solution of ethyl 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate (2.07 g, 5.10 mmol) in a mixture of 1,4-dioxane (10 mL) and water (2 mL) at 20° C. The reaction mixture was stirred at 100° C. under a nitrogen atmosphere for 2.5 hours.

[0239] The reaction mixture was extracted into dichloromethane (3×10 mL). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and evaporated to dryness under reduced pressure. The residue was purified by silica gel chromatography using a gradient of 25% to 50% ethyl acetate in petroleum ether as eluent to give 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-vinyl-1,2-dihydropyridine-3-carboxylic acid ethyl ester (0.020 mg, 0.011 mmol) as a white solid.

[0240] 1 H NMR (400MHz, DMSO-d6) δ = 12.26 (s, 1H), 7.69 (d, 1H), 7.41 (d, 1H), 7.14 (dd, 1H) ,6.05(dd,1H),5.24(d,1H),4.97(d,1H),3.9(q,2H),2.31(s,3H),0.87(t,3H)

[0241] Step 2: Synthesis of 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-vinyl-1H-pyridine-3-carboxylic acid

[0242]

[0243] To a stirred solution of 4-(3,4-dichlorophenyl)-1,6-dimethyl-2-oxo-5-vinyl-pyridine-3-carboxylic acid ethyl ester (0.125 g, 0.341 mmol) in a mixture of tetrahydrofuran (4 mL), methanol (1 mL) and water (1 mL), lithium hydroxide (0.036 g, 0.853 mmol) was added. The reaction mixture was stirred at room temperature for 18 hours. The reaction mixture was diluted with dichloromethane (10 mL) and acidified to pH 1 by adding aqueous hydrogen chloride solution (2 M). Dichloromethane was added to dissolve the precipitated solid and separate the phases. The organic extract was washed with water (2 × 10 mL) and then evaporated to dryness under reduced pressure to obtain 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-vinyl-1H-pyridine-3-carboxylic acid (0.035 g, 0.11 mmol) as a white solid.

[0244] 1 H NMR (400MHz, DMSO-d6)δ=7.65(d,1H),7.37(s,1H),7.09(d,1H),5.95(dd,1H),5.30(m,1H),5.06(dd,1H),2.39(s,3H)

[0245] Example 6: Synthesis of 4-(3,4-dichlorophenyl)-5-ethyl-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (Compound 10)

[0246] Step 1: Synthesis of ethyl 4-(3,4-dichlorophenyl)-5-ethyl-6-methyl-2-oxo-1H-pyridine-3-carboxylate

[0247]

[0248] Platinum (IV) oxide (0.0908 g, 0.400 mmol) was added to a solution of 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-vinyl-1H-pyridine-3-carboxylic acid ethyl ester (0.704 g, 2.00 mmol) in ethyl acetate (10 mL). The reaction mixture was stirred for 1 hour at room temperature under a hydrogen atmosphere (provided via a balloon). The reaction mixture was filtered and the residue was washed with ethyl acetate (10 mL). The organic filtrate was dried over anhydrous sodium sulfate, filtered and evaporated to dryness under reduced pressure. The crude residue was purified by silica gel chromatography using ethyl acetate with a gradient of 10% to 20% in petroleum ether as eluent to obtain 4-(3,4-dichlorophenyl)-5-ethyl-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid (0.030 g, 0.085 mmol) as a white solid.

[0249] 1 H NMR (400MHz, DMSO-d6)δ=12.10(s,1H),7.71(d,1H),7.48(d,1H),7.20(dd,1H),3.87(q,2H),2.11(s,3H),2.10(dd,2H),0.86-0.77(m,6H)

[0250] Step 2: Synthesis of 4-(3,4-dichlorophenyl)-5-ethyl-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid

[0251]

[0252] Prepared as described for 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid from ethyl 4-(3,4-dichlorophenyl)-5-ethyl-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.150 g, 0.341 mmol) and lithium hydroxide (0.051 g, 1.22 mmol) at room temperature for 16 hours to give 4-(3,4-dichlorophenyl)-5-ethyl-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (0.012 g, 0.025 mmol) as a white solid.

[0253] 1H NMR (400MHz, DMSO-d6) δ = 7.64 (d, J = 8.0Hz, 1H), 7.39 (s, 1H), 7.11 (d, J = 8.0Hz, 1H), 2.39 (s, 3H), 2.08 (q, 2H), 0.79 (t, 3H)

[0254] Example 7: Synthesis of 4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylic acid (Compound 9)

[0255] Step 1: Synthesis of ethyl 4-chloro-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylate

[0256]

[0257] Phosphorus oxychloride (3.90 mL, 25.5 mmol) and benzyl (triethyl) ammonium chloride (4.22 g, 18.5 mmol) were added to a solution of 4-hydroxy-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.987 g, 4.63 mmol) in acetonitrile (20 mL) at room temperature. The reaction mixture was heated at 80 ° C for 1 hour with stirring. The reaction mixture was evaporated to dryness under reduced pressure, diluted with saturated aqueous sodium bicarbonate solution (15 mL) and extracted into dichloromethane (3×15 mL). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and evaporated to dryness. The crude residue was purified by preparative thin layer chromatography to give 4-chloro-5,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid ethyl ester (0.519 g, 2.26 mmol) as a white solid.

[0258] LCMS(ESI)C 10 H 13 ClNO3[M+H] + m / z calculated: 230.05, found: 230.1

[0259] Step 2: Synthesis of ethyl 4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylate

[0260]

[0261] To a stirred solution of 4-chloro-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.413 g, 1.80 mmol) in a mixture of 1,4-dioxane (5 mL) and water (1.2 mL) at room temperature, (3,4-dichlorophenyl)boronic acid (0.412 g, 2.16 mmol), [1,1'-bis(diphenylphosphino)ferrocene](II) (0.132 g, 0.180 mmol) and dipotassium carbonate (0.498 g, 3.60 mmol) were added in sequence. The reaction mixture was heated at 85 ° C. under a nitrogen atmosphere for 5 hours with stirring. The cooled reaction mixture was extracted into ethyl acetate (3×15 mL), and the combined organic extracts were dried over anhydrous sodium sulfate, filtered and evaporated to dryness under reduced pressure. The crude residue was purified by preparative HPLC to give ethyl 4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylate (0.130 g, 0.38 mmol) as a white solid.

[0262] 1 H NMR (400MHz, DMSO-d6)δ=12.10(s,1H),7.72(d,1H),7.45(d,1H),7.17(dd,1H),3.87(m,2H),2.45(s,3H),1.68(s,3H),0.85(t,3H)

[0263] Step 3: Synthesis of 4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylic acid

[0264]

[0265] At room temperature, lithium hydroxide (0.070 g, 2.94 mmol) was added to a stirred solution of 4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.200 g, 0.588 mmol) in a mixture of tetrahydrofuran (1 mL), methanol (1 mL) and water (1 mL). The reaction mixture was heated at 50 ° C for 4 hours under stirring. The cooled reaction mixture was diluted with dichloromethane (10 mL), and the aqueous phase was adjusted to pH 3 by adding aqueous hydrogen chloride solution (1 M). The phases were separated, and the aqueous phase was extracted into dichloromethane (3×10 mL). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and evaporated to dryness under reduced pressure. The crude residue was purified by preparative HPLC to give 4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid (0.076 g, 0.24 mmol) as a white solid.

[0266] 1 H NMR (400MHz, DMSO-d6)δ=15.18(s,1H),13.24(s,1H),7.68(d,1H),7.39(d,1H),7.08(dd,1H),2.38(s,3H),1.65(s,3H)

[0267] Example 8: Synthesis of 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (Compound 11)

[0268] Step 1: Synthesis of ethyl 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate

[0269]

[0270] To a stirred solution of 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.200 g, 0.494 mmol) in N,N-dimethylformamide (5.0 mL) was added copper cyanide (0.111 g, 1.23 mmol). The reaction mixture was heated at 160 ° C for 3 hours with stirring. The cooled reaction mixture was quenched by adding water (30 mL) and extracted into ethyl acetate (3×30 mL). The combined organic extracts were washed with brine, dried over anhydrous sodium sulfate, filtered and evaporated to dryness under reduced pressure. The crude residue was purified by preparative HPLC to give 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid ethyl ester (0.126 g, 0.36 mmol) as a white powder.

[0271] 1 H NMR (400MHz, DMSO-d6)δ=7.81(d,1H),7.66(d,1H),7.36(dd,1H),3.99(q,2H),2.48(s,3H),0.92(t,3H)

[0272] Step 2: Synthesis of 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid

[0273]

[0274] Prepared from ethyl 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylate (0.100 g, 0.285 mmol) and lithium hydroxide (0.017 mg, 0.712 mmol) as described for 5-bromo-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid at room temperature for 12 hours to give 5-cyano-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-1H-pyridine-3-carboxylic acid (0.030 g, 0.093 mmol) as a white solid.

[0275] 1 H NMR (400MHz, DMSO-d6) δ = 7.63 (d, 1H), 7.47 (s, 1H), 7.18 (d, 1H), 2.43 (s, 3H)

[0276] Example 9: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 13)

[0277] Step 1: Synthesis of 4-(3,4-dichlorophenyl)but-3-yn-2-ol

[0278]

[0279] To a solution of 4-bromo-1,2-dichloro-benzene (5.00 g, 22.1 mmol) in acetonitrile (32.5 mL) was added but-3-yn-2-ol (1.94 g, 27.7 mmol), followed by N,N-diethylethylamine (6.38 g, 63 mmol), triphenylphosphine (0.0581 g, 0.22 mmol), copper iodide (0.0426 g, 0.22 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.092 g, 0.078 mmol). The reaction mixture was flushed with nitrogen and heated at 60 ° C for 18 hours. The cooled reaction mixture was evaporated to dryness under reduced pressure and distributed between ethyl acetate (200 mL) and water (150 mL). The aqueous phase was extracted into ethyl acetate (200 mL). The combined organic extracts were washed with water and then washed with brine, dried over anhydrous magnesium sulfate, filtered and evaporated to dryness under reduced pressure. The crude residue was purified by flash chromatography on silica gel using a gradient of 5% to 30% ethyl acetate in cyclohexane as eluent to give 4-(3,4-dichlorophenyl)but-3-yn-2-ol (3.72 g, 17.3 mmol) as a brown solid.

[0280] 1H NMR (400 MHz, chloroform) δ=7.51 (s, 1H), 7.38 (d, 1H), 7.24 (dd, 1H), 4.80-4.68 (m, 1H), 1.96 (d, 1H), 1.55 (d, 3H)

[0281] Step 2: Synthesis of 4-(3,4-dichlorophenyl)but-3-yn-2-one

[0282]

[0283] To a solution of 4-(3,4-dichlorophenyl)but-3-yn-2-ol (3.71g, 17.2mmol) in tetrahydrofuran (52mL) was added manganese dioxide (7.50g, 86.2mmol). The reaction mixture was stirred at room temperature for 3.5 hours. Manganese dioxide (4.50g, 51.7mmol) was added in addition, and the reaction mixture was stirred at room temperature for another 18 hours. The reaction mixture was filtered through diatomaceous earth and washed with ethyl acetate (300mL). The organic filtrate was evaporated to dryness under reduced pressure, and the crude residue was purified by flash chromatography on silica gel using ethyl acetate with a gradient of 1% to 10% in cyclohexane as eluent to obtain 4-(3,4-dichlorophenyl)but-3-yn-2-one (2.87g, 13.5mmol).

[0284] 1 H NMR (400 MHz, chloroform) δ=7.66 (d, 1H), 7.48 (d, 1H), 7.40 (dd, 1H), 2.45 (s, 3H)

[0285] Step 3: Synthesis of methyl 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyran-3-carboxylate

[0286]

[0287] Under nitrogen and at room temperature, tetrahydrofuran (17mL) was added to a suspension of sodium hydride in mineral oil (60% by mass, 0.090g, 2.3mmol), followed by dimethyl malonate (A, 0.71g, 5.4mmol, 0.62mL). The reaction mixture was stirred at room temperature for 5 minutes, followed by the addition of a solution of 4-(3,4-dichlorophenyl) but-3-yn-2-one (0.96g, 4.5mmol) in tetrahydrofuran (15mL). The reaction mixture was stirred at room temperature for 18 hours. Aluminum chloride (0.063g, 0.47mmol) was added, while the reaction mixture was covered with nitrogen, and the mixture was stirred at room temperature for 18 hours. The reaction mixture was quenched by adding a saturated aqueous ammonium chloride solution, and evaporated under reduced pressure to remove tetrahydrofuran. Ethyl acetate (100mL) and water (60mL) were added and the aqueous phase was extracted into ethyl acetate (50mL). The combined organic extracts were washed with brine, dried over anhydrous magnesium sulfate, filtered and evaporated under reduced pressure. The crude residue was purified by flash chromatography on silica gel using a gradient of 5% to 30% ethyl acetate in cyclohexane as eluent to give 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyran-3-carboxylic acid methyl ester (0.76 g, 2.4 mmol) as a yellow solid.

[0288] 1 H NMR (400 MHz, chloroform) δ=7.52 (d, 1H), 7.48 (d, 1H), 7.22 (dd, 1H), 6.08 (d, 1H), 3.73 (s, 3H), 2.34 (d, 3H)

[0289] Step 4: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0290]

[0291] At room temperature and under nitrogen atmosphere, to 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyran-3-carboxylic acid methyl ester (0.100g, 0.32mmol) in N, N-dimethylformamide (1.5mL) solution, add 4-chloro-2-fluoro-aniline (0.070g, 0.48mmol), then add scandium trifluoromethanesulfonate (0.158g, 0.32mmol). The reaction mixture was stirred at room temperature for 3 days. Saturated aqueous ammonium chloride solution (4mL) and ethyl acetate (20mL) were added. The aqueous phase was extracted into ethyl acetate (20mL), and the combined organic extracts were evaporated to dryness under reduced pressure. The crude residue was purified by mass directed reverse phase HPLC to give 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.029 g, 0.068 mmol) as a brown solid.

[0292] 1 H NMR (400 MHz, chloroform) δ=14.42-13.87 (m, 1H), 7.50 (d, 1H), 7.45-7.38 (m, 3H), 7.26 (s, 1H), 7.17 (dd, 1H), 6.38 (s, 1H), 2.19 (s, 3H)

[0293] Example 10: Synthesis of 5-chloro-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 25)

[0294]

[0295] To a solution of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.120 g, 0.28 mmol) in acetonitrile (2.0 mL) was added 1-chloropyrrolidine-2,5-dione (0.035 g, 0.26 mmol). The reaction mixture was heated at 80 ° C for 3 hours with stirring. The cooled reaction mixture was evaporated to dryness under reduced pressure and purified by mass-directed reverse phase HPLC to give 5-chloro-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.32 mg, 0.069 mmol) as a paste solid.

[0296] 1 H NMR (400 MHz, methanol) δ=7.56 (dd, 1H), 7.46-7.40 (m, 3H), 7.36-7.29 (m, 1H), 7.13 (ddd, 1H), 2.34 (s, 3H)

[0297] Example 11: Synthesis of 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 21)

[0298] Step 1: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester

[0299]

[0300] To a cooled (ice bath) solution of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (1.3 g, 3.0 mmol) in dichloromethane (20 mL) was added oxalyl chloride (0.73 g, 5.7 mmol) followed by catalytic N,N-dimethylformamide (0.2 mL). The reaction mixture was stirred at room temperature for 1 hour. The resulting acid chloride solution was cooled to 0 ° C and methanol (10 mL) was added. The reaction mixture was stirred at room temperature for 0.5 hours. The reaction mixture was evaporated to dryness under reduced pressure. Water and dichloromethane were added and the phases were separated. The organic phase was evaporated to dryness under reduced pressure and the crude residue was purified by flash chromatography on silica gel using a gradient of 10% to 90% ethyl acetate / ethanol (3:1) in cyclohexane as eluent to give 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (1.07 g, 2.43 mmol) as a pink solid.

[0301] 1 H NMR (400 MHz, chloroform) δ=7.55 (d, 1H), 7.51 (d, 1H), 7.35-7.32 (m, 1H), 7.32-7.29 (m, 1H), 7.27 (d, 1H), 7.25-7.21 (m, 1H), 6.17 (d, 1H), 3.72 (s, 3H), 2.09 (s, 3H)

[0302] Step 2: Synthesis of 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester

[0303]

[0304] 2,2,2-trifluoroacetic acid (0.30 g, 2.6 mmol) was added to a suspension of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (1.07 g, 2.43 mmol) in acetonitrile (20 mL). The suspension was heated at 80 ° C to obtain a solution, to which N-bromosuccinimide (0.450 g, 2.53 mmol) was added. The reaction mixture was heated at 80 ° C for 1 hour. The cooled reaction mixture was evaporated to dryness under reduced pressure and purified by reverse phase flash chromatography on C-18 silica gel using a gradient of acetonitrile in water to obtain 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (1.10 g, 2.1 mmol) as a paste solid.

[0305] 1 H NMR (400 MHz, chloroform) δ=7.52 (dd, 1H), 7.47-7.38 (m, 1H), 7.38-7.31 (m, 2H), 7.26-7.21 (m, 1H), 7.20-7.11 (m, 1H), 3.62 (s, 3H), 2.31 (s, 3H)

[0306] Step 3: Synthesis of 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0307]

[0308] To a solution of 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.100 g, 0.19 mmol) in methanol (3.0 mL) was added lithium hydroxide hydrate (0.040 g, 0.95 mmol) and water (1.0 mL). The reaction mixture was heated at 70 ° C for 1 hour. The cooled reaction mixture was diluted with water, acidified to pH 1 by adding aqueous hydrogen chloride solution, and the resulting precipitate was extracted into dichloromethane. The organic extracts were evaporated to dryness under reduced pressure and the crude residue was purified by reverse phase flash chromatography on C-18 silica gel using a gradient of acetonitrile in water to give 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.030 g, 0.060 mmol) as a cream solid.

[0309] 1H NMR (400 MHz, chloroform) δ=7.55 (dd, 1H), 7.46-7.40 (m, 2H), 7.28 (brd, 1H), 7.26-7.20 (m, 1H), 6.99 (ddd, 1H), 2.43 (s, 3H)

[0310] Example 12: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-pyridine-3-carboxylic acid (Compound 26)

[0311] Step 1: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-pyridine-3-carboxylic acid methyl ester

[0312]

[0313] To a solution of 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.200 g, 0.38 mmol) in a degassed mixture of acetonitrile (8 mL) and water (2 mL), methylboric acid (0.040 g, 0.67 mmol), SPhos Pd G4 catalyst (0.060 g, 0.076 mmol) and potassium carbonate (0.200 g, 1.4 mmol) were added sequentially. The reaction mixture was purged with nitrogen and heated at 100 ° C for 0.5 hours under microwave irradiation. The reaction mixture was filtered through diatomaceous earth, and the filtrate was diluted with water and extracted into dichloromethane. The combined organic extracts were dried over anhydrous magnesium sulfate, filtered and evaporated to dryness under reduced pressure. The crude residue was purified by reverse phase HPLC to give 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.030 g, 0.059 mmol) as a dark orange gum.

[0314] 1 H NMR (400 MHz, chloroform) δ=7.52 (dd, 1H), 7.41-7.34 (m, 1H), 7.32 (td, 2H), 7.26-7.20 (m, 1H), 7.11 (ddd, 1H), 3.60 (s, 3H), 2.07 (s, 3H), 1.85 (s, 3H)

[0315] Step 2: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-pyridine-3-carboxylic acid

[0316]

[0317] Prepared as described for 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid from 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.030 g, 0.059 mmol) and lithium hydroxide hydrate (0.040 g, 0.95 mmol) at 80 °C to give 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5,6-dimethyl-2-oxo-pyridine-3-carboxylic acid (0.025 g, 0.051 mmol) as a cream solid.

[0318] 1 H NMR (400 MHz, chloroform) δ=14.30 (brs, 1H), 7.54 (dd, 1H), 7.43-7.39 (m, 2H), 7.28-7.26 (m, 1H), 7.21 (dd, 1H), 6.96 (ddd, 1H), 2.20 (s, 3H), 1.85 (s, 3H)

[0319] Example 13: Synthesis of 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 36)

[0320] Step 1: Synthesis of 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0321]

[0322] Prepared as described for 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyran-3-carboxylic acid from 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyran-3-carboxylic acid methyl ester (0.500 g, 1.6 mmol) and 2,4-difluoroaniline (0.250 g, 1.9 mmol) in N,N-dimethylformamide (5 mL) at room temperature in the presence of scandium trifluoromethanesulfonate (0.800 g, 1.6 mmol) to give after purification 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.540 g, 1.316 mmol).

[0323] 1H NMR (400 MHz, chloroform) δ = 7.50 (d, J = 8.3 Hz, 1H), 7.43 (d, 1H), 7.36-7.28 (m, 1H), 7.20-7.11 (m, 3H), 6.37 (s, 1H), 2.19 (s, 3H).

[0324] Step 2: Synthesis of 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester

[0325]

[0326] Prepared from 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (1.15 g, 2.80 mmol) and oxalyl chloride (0.73 g, 5.7 mmol) in dichloromethane (20 mL) at room temperature in the presence of catalytic N,N-dimethylformamide as described for 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester, followed by quenching with methanol (10 mL), gave 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (1.07 g, 2.52 mmol) as a pink solid after purification.

[0327] 1 H NMR (400 MHz, chloroform) δ=7.56 (d, 1H), 7.51 (d, 1H), 7.32-7.26 (m, 2H), 7.09-7.01 (m, 2H), 6.17 (d, 1H), 3.72 (s, 3H), 2.09 (s, 3H)

[0328] Step 3: Synthesis of 5-bromo-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester

[0329]

[0330] Prepared as described for 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester from 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.640 g, 1.5 mmol) and N-bromosuccinimide (0.280 g, 1.6 mmol) in acetonitrile (10 mL) in the presence of 2,2,2-trifluoroacetic acid (0.04 mL, 0.5 mmol) at 80 °C for 1 hour to give 5-bromo-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.430 g, 0.85 mmol) as a cream solid after purification.

[0331] 1 H NMR (400 MHz, chloroform) δ=7.52 (dd, 1H), 7.48-7.38 (m, 1H), 7.33-7.26 (m, 1H), 7.21-7.12 (m, 1H), 7.11-7.01 (m, 2H), 3.62 (s, 3H), 2.31 (s, 3H)

[0332] Step 4: Synthesis of methyl 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylate

[0333]

[0334] To a mixture of 5-bromo-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.200 g, 0.40 mmol), 1,1'-bis(diphenylphosphino)ferrocenepalladium(II) dichloride and dichloromethane complex (0.060 g, 0.073 mmol) and methoxymethyl potassium trifluoroborate (0.150 g, 0.99 mmol) was added 1,4-dioxane (5 mL) and water (1 mL). Cesium carbonate (0.390 g, 1.20 mmol) was added to this stirred mixture, after which the reaction mixture was heated at 120 ° C for 1 hour under microwave irradiation. The cooled reaction mixture was filtered and then diluted with water and dichloromethane. The phases were separated and the organic extract was evaporated to dryness under reduced pressure. The crude residue was purified by mass directed reverse phase HPLC to give 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.020 g, 0.043 mmol) as a beige solid.

[0335] 1 H NMR (400 MHz, chloroform) δ=7.52 (d, 2H), 7.28-7.18 (m, 2H), 7.11-7.00 (m, 2H), 4.00-3.80 (m, 2H), 3.61 (s, 3H), 3.21 (d, 3H), 2.17 (s, 3H)

[0336] Step 5: Synthesis of 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0337]

[0338] To a solution of 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.017g, 0.036mmol) in methanol (1.0mL), lithium hydroxide hydrate (0.010g, 0.24mmol) and water (0.1mL) are added. The solution is heated at 80°C for 2 hours. The reaction mixture is poured into water, acidified to pH 1 by adding aqueous hydrogen chloride solution (2M), and the resulting precipitate is extracted into dichloromethane. Each phase is separated, and the organic extract is evaporated to dryness under reduced pressure to obtain 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.015g, 0.030mmol) as a beige solid.

[0339] 1 H NMR (400 MHz, chloroform) δ=14.16 (brs, 1H), 7.53 (d, 1H), 7.36-7.27 (m, 2H), 7.18-7.10 (m, 2H), 7.06 (ddd, 1H), 3.97-3.77 (m, 2H), 3.15 (d, 3H), 2.28 (s, 3H)

[0340] Example 14: Synthesis of 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 37)

[0341] Step 1: Synthesis of 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0342]

[0343] Under stirring, cesium carbonate (0.400g, 1.2mmol) is added to a mixture of 5-bromo-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-formic acid methyl ester (0.200g, 0.40mmol), 1,1'-bis(diphenylphosphino)ferrocene palladium dichloride (ii) and dichloromethane (0.100g, 0.12mmol) and cyclopropyl trifluoroborate potassium (0.115g, 0.78mmol) in 1,4-dioxane (5mL) and water (1mL). The reaction mixture is heated at 120°C for 50 minutes under microwave radiation. The cooled reaction mixture is filtered and then diluted with dichloromethane and water. Each phase is separated, and the organic extract is evaporated to dryness under reduced pressure. The crude residue was purified by reverse phase flash chromatography on C-18 silica gel using a gradient of acetonitrile in water to give 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.090 g, 0.19 mmol) as a beige solid.

[0344] 1 H NMR (400 MHz, chloroform) δ=7.56-7.43 (m, 2H), 7.26-7.14 (m, 2H), 7.09-7.00 (m, 2H), 3.63 (s, 3H), 2.23 (s, 3H), 1.54-1.46 (m, 1H), 0.66 (br s, 2H), 0.26-0.08 (m, 2H)

[0345] Step 2: Synthesis of 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid

[0346]

[0347] Prepared as described for 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid from 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.090 g, 0.19 mmol) and lithium hydroxide hydrate (0.050 g, 1.2 mmol) in methanol (10 mL) and water (1 mL) at 80 °C to give 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.087 g, 0.19 mmol) as a beige solid.

[0348] 1H NMR (400 MHz, chloroform) δ=14.35 (brs, 1H), 7.51 (dd, 1H), 7.33-7.27 (m, 2H), 7.18-7.10 (m, 2H), 7.06 (ddd, 1H), 2.33 (s, 3H), 1.50-1.37 (m, 1H), 0.79-0.54 (m, 2H), 0.31-0.12 (m, 2H)

[0349] Example 15: Synthesis of 1-(3-chloro-5-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-prop-1-ynyl-pyridine-3-carboxylic acid (Compound 40)

[0350] Step 1: Synthesis of 1-(3-chloro-5-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-prop-1-ynyl-pyridine-3-carboxylic acid methyl ester

[0351]

[0352] Prepared as described for 5-cyclopropyl-4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester from 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.200 g, 0.38 mmol) and potassium trifluoro(prop-1-ynyl)borohydride (0.080 g, 0.55 mmol) at 120 °C for 1 hour to give 1-(3-chloro-5-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-prop-1-ynyl-pyridine-3-carboxylic acid methyl ester (0.025 g, 0.052 mmol) as a beige solid.

[0353] 1 H NMR (400 MHz, chloroform) δ=7.55 (d, 1H), 7.49 (d, 1H), 7.36-7.30 (m, 3H), 7.24-7.22 (m, 1H), 3.65 (s, 3H), 2.27 (s, 3H), 1.85 (s, 3H)

[0354] Step 2: Synthesis of 1-(3-chloro-5-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-prop-1-ynyl-pyridine-3-carboxylic acid

[0355]

[0356] Prepared as described for 4-(3,4-dichlorophenyl)-1-(2,4-difluorophenyl)-5-(methoxymethyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid from 1-(3-chloro-5-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-prop-1-ynyl-pyridine-3-carboxylic acid methyl ester (0.020 g, 0.025 mmol) and lithium hydroxide hydrate (0.000 g, 0.24 mmol) in methanol (3 mL) and water (0.5 mL) at 80 °C to give 1-(3-chloro-5-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-5-prop-1-ynyl-pyridine-3-carboxylic acid (0.009 g, 0.017 mmol) as a cream solid.

[0357] 1 H NMR (400 MHz, chloroform) δ=7.51 (dd, 1H), 7.44-7.39 (m, 2H), 7.34 (dd, 1H), 7.29-7.23 (m, 1H), 7.11-7.03 (m, 1H), 2.37 (s, 3H), 1.81 (s, 3H)

[0358] Example 16: Synthesis of 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5-hydroxy-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 42)

[0359]

[0360] To a solution of 5-bromo-1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid methyl ester (0.200 g, 0.38 mmol) in methanol (5 mL) was added lithium hydroxide hydrate (0.220 g, 5.2 mmol) and water (5 mL). The reaction mixture was heated at 90 ° C for 2 hours. The reaction mixture was poured into water, acidified to pH 1 by adding aqueous hydrogen chloride solution (2 M), and the resulting precipitate was extracted into dichloromethane. The organic extracts were evaporated to dryness under reduced pressure and the crude residue was purified by reverse phase flash chromatography on C-18 silica gel using a gradient of acetonitrile in water to give 1-(4-chloro-2-fluoro-phenyl)-4-(3,4-dichlorophenyl)-5-hydroxy-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.022 g, 0.050 mmol) as a light orange solid.

[0361] 1H NMR (400MHz, DMSO-d6)δ=7.79(dd,1H),7.73(d,1H),7.64-7.59(m,1H),7.57(d,1H),7.55-7.50(m,1H),7.31(dd,1H),2.01(s,3H)

[0362] Example 17: Synthesis of 1-[(4-chloro-2-fluoro-phenyl)methyl]-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (Compound 22)

[0363]

[0364] Scandium trifluoromethanesulfonate (0.320g, 0.64mmol) and (4-chloro-2-fluoro-phenyl) methylamine (0.105g, 0.658mmol) are added to a solution of 4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyran-3-formic acid methyl ester (0.200g, 0.64mmol) in N,N-dimethylformamide (3mL). The reaction mixture is heated at 120°C for 1 hour under microwave radiation, and then heated for another 2 hours. The reaction mixture is poured into water, acidified to pH 1 and extracted into dichloromethane by adding aqueous hydrogen chloride solution (2M). The organic extract was evaporated to dryness under reduced pressure to give a crude residue, which was purified by reverse phase flash chromatography on C-18 silica gel using a gradient of acetonitrile in water to give 1-[(4-chloro-2-fluoro-phenyl)methyl]-4-(3,4-dichlorophenyl)-6-methyl-2-oxo-pyridine-3-carboxylic acid (0.060 g, 0.14 mmol) as a yellow solid.

[0365] 1 H NMR (400 MHz, chloroform) δ=7.47 (d, 1H), 7.37 (d, 1H), 7.20-7.08 (m, 4H), 6.28 (s, 1H), 5.44 (s, 2H), 2.49 (s, 3H)

[0366] Table 2: Selected compounds of the invention 1 H NMR data.

[0367]

[0368]

[0369]

[0370]

[0371]

[0372]

[0373]

[0374]

[0375]

[0376]

[0377]

[0378]

[0379]

[0380]

[0381]

[0382]

[0383] Biological Examples

[0384] Seeds of the following test species (Amaranthus palmeri (AMAPA), Amaranthus retoflexus (AMARE), Echinochloa crus-galli (ECHCG), Zeamays (ZEAMX), Ipomoea hederacea (IPOHE), and Setaria faberi (SETFA)) were sown in standard soil in pots. After 8 days of cultivation under controlled conditions in a greenhouse (at 24°C / 16°C, day / night; 14 h light; 65% humidity), the plants were sprayed with an aqueous spray solution derived from a formulation of the technical grade active ingredient in acetone / water (50:50) solution containing 0.5% Tween 20 (polyoxyethylene sorbitan monolaurate, CAS RN 9005-64-5). Unless otherwise stated, the compounds were applied at 1000 g / ha. These test plants were then grown in a greenhouse under controlled conditions in a greenhouse (at 24°C / 16°C, day / night; 14 hours of light; 65% humidity) and watered twice daily. After 13 days, the percentage of damage to the plants caused by the test was evaluated. The following table shows biological activity on a five-point scale (5 = 81%-100%; 4 = 61%-80%; 3 = 41%-60%; 2 = 21%-40%; 1 = 1%-20%; 0 = no damage to plants; - = not tested).

[0385] Table B1: Pre-emergence test

[0386]

[0387]

[0388] Table B2: Post-emergence testing

[0389]

[0390]

Claims

1. A compound having formula (I) or a salt thereof: in R 1 is hydrogen, C1-C6 alkyl, phenyl, phenylC1-C2 alkyl, heteroaryl, or heteroarylC1-C2 alkyl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms independently selected from N, O and S, and wherein each of the phenyl and heteroaryl moieties may be optionally substituted by 1, 2, 3 or 4 residues which may be the same or different and are represented by R 5 The group represented by is substituted; R 2 is hydrogen or C1-C6 alkyl; R 3 is hydrogen, halogen, cyano, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, or C2-C6 alkynyl; R 4 is optionally replaced by 1, 2, 3 or 4 which may be the same or different. 6 The group represented is substituted phenyl; R 5 is halogen, cyano, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 alkoxyC1-C6 alkyl, or nitro; and R 6 It is cyano, nitro, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 haloalkoxy, C1-C6 alkoxyC1-C6 alkyl, C1-C6 alkylsulfanyl, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfonyl, C1-C6 alkylsulfonylamino, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 alkylaminocarbonyl, C3-C6 cycloalkyl, C3-C6 cycloalkylaminocarbonyl, or N,N-di(C1-C4 alkyl)aminocarbonyl.

2. The compound according to claim 1, wherein R 1 is hydrogen, C1-C6 alkyl, phenyl, phenylC1-C2 alkyl, heteroaryl, or heteroarylC1-C2 alkyl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, and wherein each of the phenyl and heteroaryl moieties may be optionally substituted by 1, 2 or 3 residues which may be the same or different and are represented by R 5 The group represented is substituted.

3. The compound according to claim 1 or claim 2, wherein R 1 is hydrogen, C1-C3 alkyl, phenyl, phenylC1-C2 alkyl, or heteroaryl, wherein each heteroaryl moiety is a 5- or 6-membered aromatic monocyclic ring containing a single nitrogen atom, and wherein each of the phenyl and heteroaryl moieties may be optionally substituted by 1 or 2 residues which may be the same or different and are represented by R 5 The group represented is substituted.

4. The compound according to any one of claims 1 to 3, wherein R 2 It is a C1-C3 alkyl group.

5. The compound according to any one of claims 1 to 4, wherein R 3 It is hydrogen, halogen, cyano, hydroxy, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl, C3-C6 cycloalkyl, C2-C3 alkenyl, or C2-C4 alkynyl.

6. The compound according to any one of claims 1 to 5, wherein R 4 is optionally replaced by 1 or 2 which may be the same or different from R 6 The group represents a phenyl group substituted with.

7. The compound according to any one of claims 1 to 6, wherein R 5 It is halogen, cyano, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 haloalkoxy, C1-C3 alkoxyC1-C3 alkyl, or nitro.

8. The compound according to any one of claims 1 to 7, wherein R 6 It is cyano, nitro, halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, C1-C3 alkoxyC1-C3 alkyl, C1-C3 alkylsulfanyl, C1-C3 alkylsulfonyl, C1-C2 alkylcarbonyl, C1-C3 alkoxycarbonyl, or N,N-di(C1-C2 alkyl)aminocarbonyl.

9. The compound according to any one of claims 1 to 7, wherein R 6 is cyano, nitro, or halogen.

10. The compound according to any one of claims 1 to 9, wherein R 4 It is 3,4-dichlorophenyl.

11. A herbicidal composition comprising a compound according to any one of the preceding claims and an agriculturally acceptable formulation adjuvant.

12. The herbicidal composition according to claim 11, further comprising at least one additional pesticide.

13. The herbicidal composition according to claim 12, wherein The additional pesticide is a herbicide or a herbicide safener.

14. A method of controlling weeds at a locus, the method comprising applying to the locus a weed controlling amount of a composition according to any one of claims 11 to 13.

15. Use of a compound of formula (I) according to any one of claims 1 to 10 as a herbicide.